Successful removal of a perforating ventricular lead after idarucizumab administration.
Kardiol Pol
; 78(4): 350-351, 2020 04 24.
Article
in En
| MEDLINE
| ID: mdl-32024809
Full text:
1
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
Dabigatran
Limits:
Humans
Language:
En
Year:
2020
Type:
Article